Literature DB >> 17627190

Extracorporeal cardiac shock wave therapy improves left ventricular remodeling after acute myocardial infarction in pigs.

Toyokazu Uwatoku1, Kenta Ito, Kohtaro Abe, Keiji Oi, Takatoshi Hizume, Kenji Sunagawa, Hiroaki Shimokawa.   

Abstract

OBJECTIVE: We have recently demonstrated that low-energy extracorporeal shock wave therapy improves chronic myocardial ischemia in pigs and humans. In this study, we examined whether our shock wave therapy is also effective at improving left ventricular remodeling after acute myocardial infarction in pigs.
METHODS: Acute myocardial infarction was created by surgically excising the proximal segment of the left circumflex coronary artery (n=20). In the early treatment protocol, the shock wave therapy was started 3 days after acute myocardial infarction, whereas in the late treatment protocol, the therapy was started 4 weeks after acute myocardial infarction (n=5 each). The remaining animals were treated in the same manner, but without the shock wave treatment in each protocol (n=5 each).
RESULTS: In the early treatment protocol, left ventricular ejection fraction was higher (42+/-1 vs. 32+/-1%, P<0.001) and left ventricular end-diastolic volume was smaller (95+/-1 vs. 99+/-2 ml, P<0.05) in the shock wave group compared with the control group. Furthermore, wall thickening fraction (32+/-1 vs. 28+/-1%, P<0.01), regional myocardial blood flow (1.7+/-0.2 vs. 1.0+/-0.1 ml/min/g, P<0.01), and number of capillaries in the border zone (1348+/-15 vs. 938+/-34 mm2, P<0.0001) were all significantly improved in the shock wave group compared with the control group. By contrast, in the late treatment group, no such beneficial effects of the shock wave therapy were noted.
CONCLUSION: These results suggest that our extracorporeal cardiac shock wave therapy is also an effective and noninvasive therapy for improving left ventricular remodeling after acute myocardial infarction when started in the early phase of the disorder.

Entities:  

Mesh:

Year:  2007        PMID: 17627190     DOI: 10.1097/MCA.0b013e328089f19b

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  29 in total

1.  Study of vascular injuries using endothelial denudation model and the therapeutic application of shock wave: a review.

Authors:  Cheuk-Kwan Sun; Pei-Lin Shao; Ching-Jen Wang; Hon-Kan Yip
Journal:  Am J Transl Res       Date:  2011-04-08       Impact factor: 4.060

2.  Shock Wave Enhances Angiogenesis through VEGFR2 Activation and Recycling.

Authors:  Tien-Hung Huang; Cheuk-Kwan Sun; Yi-Ling Chen; Ching-Jen Wang; Tsung-Cheng Yin; Mel S Lee; Hon-Kan Yip
Journal:  Mol Med       Date:  2016-12-06       Impact factor: 6.354

3.  It Comes As a Shock: Kidney Repair Using Shockwave Therapy.

Authors:  Nattawat Klomjit; Amir Lerman; Lilach O Lerman
Journal:  Hypertension       Date:  2020-11-02       Impact factor: 10.190

4.  Randomized and double-blind controlled clinical trial of extracorporeal cardiac shock wave therapy for coronary heart disease.

Authors:  Ping Yang; Tao Guo; Wei Wang; Yun-Zhu Peng; Yu Wang; Ping Zhou; Zhi-Ling Luo; Hong-Yan Cai; Ling Zhao; Hong-Wen Yang
Journal:  Heart Vessels       Date:  2012-03-30       Impact factor: 2.037

5.  Extracorporeal shockwave myocardial therapy is efficacious in improving symptoms in patients with refractory angina pectoris--a multicenter study.

Authors:  Megha Prasad; Wan Azman Wan Ahmad; Renan Sukmawan; Edward-Bengie L Magsombol; Andrew Cassar; Yuri Vinshtok; Muhammad Dzafir Ismail; Ahmad Syadi Mahmood Zuhdi; Sue Ann Locnen; Rodney Jimenez; Homobono Callleja; Amir Lerman
Journal:  Coron Artery Dis       Date:  2015-05       Impact factor: 1.439

6.  Safety and efficacy of extracorporeal shock wave myocardial revascularization therapy for refractory angina pectoris.

Authors:  Andrew Cassar; Megha Prasad; Martin Rodriguez-Porcel; Guy S Reeder; Darshak Karia; Anthony N DeMaria; Amir Lerman
Journal:  Mayo Clin Proc       Date:  2014-03       Impact factor: 7.616

Review 7.  Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2010-09-07

Review 8.  Cardiovascular applications of therapeutic ultrasound.

Authors:  Babak Nazer; Edward P Gerstenfeld; Akiko Hata; Lawrence A Crum; Thomas J Matula
Journal:  J Interv Card Electrophysiol       Date:  2013-12-03       Impact factor: 1.900

9.  A historical perspective towards a non-invasive treatment for patients with atherosclerosis.

Authors:  W Slijkhuis; W Mali; Y Appelman
Journal:  Neth Heart J       Date:  2009-04       Impact factor: 2.380

10.  The management of neuropathic ulcers of the foot in diabetes by shock wave therapy.

Authors:  Biagio Moretti; Angela Notarnicola; Giulio Maggio; Lorenzo Moretti; Michele Pascone; Silvio Tafuri; Vittorio Patella
Journal:  BMC Musculoskelet Disord       Date:  2009-05-27       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.